Latest News for: gsk

Edit

Transaction notification (Form 6-K) (GSK plc)

Public Technologies 14 Jul 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... CEO, ViiV Healthcare and President, Global Health, GSK ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc ... GSK plc.
Edit

GSK's Jemperli meets main goal in mid-stage rectal cancer trial

The Times of India 13 Jul 2026
GSK anticipates Jemperli will significantly contribute to its long-term sales targets.
Edit

Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer (Form 6-K) (GSK plc)

Public Technologies 13 Jul 2026
GSK plc ... GSK plc (LSE/NYSE ... Hesham Abdullah, Senior Vice President, Global Head Oncology, R&D, GSK, said ... GSK plans to share interim AZUR-1 data with global regulatory authorities to support review ... GSK in oncology ... About GSK ... GSK enquiries ... GSK plc.
Edit

Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer (GSK plc)

Public Technologies 13 Jul 2026
GSK plc (LSE/NYSE ... Hesham Abdullah, Senior Vice President, Global Head Oncology, R&D, GSK, said ... GSK plans to share interim AZUR-1 data with global regulatory authorities to support review ... GSK in oncology ... About GSK ... Find out more at www.gsk.com.
Edit

GSK's licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population (Form 6-K) (GSK plc)

Public Technologies 10 Jul 2026
GSK plc ... GSK's licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population ... GSK plc (LSE/NYSE. GSK) licensor Hansoh Pharmaceutical Group Co., Ltd ... GSK in oncology ... About GSK ... Find out more at www.gsk.com ... GSK ... GSK ... GSK.
Edit

Tender Offer Statement (Form SC TO-T/A) (GSK plc)

Public Technologies 10 Jul 2026
GSK PLC ... GSK PLC ... GSK plc published this content on July 10, 2026, and is solely responsible for the information contained herein.
Edit

GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population (GSK plc)

Public Technologies 10 Jul 2026
GSK is advancing risvutatug rezetecan outside China across multiple tumour types, including lung cancer, prostate cancer and other solid tumours. GSK plc (LSE/NYSE. GSK) licensor Hansoh Pharmaceutical Group Co., Ltd ... GSK in oncology ... About GSK.
Edit

Roy Jakobs to join GSK Board as Non-Executive Director (GSK plc)

Public Technologies 09 Jul 2026
GSK plc (LSE/NYSE. GSK) has today announced that Roy Jakobs will join the Board of the Company as a Non-Executive Director from 13 July 2026 ... Sir Jonathan Symonds, Chair of GSK said, "We are delighted to welcome Roy to the Board ... About GSK.
Edit

GSK plc (the 'Company') Transaction notification (Form 6-K) (GSK plc)

Public Technologies 09 Jul 2026
GSK plc ... GSK plc (the 'Company') ... GSK plc ... Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account ... About GSK ... Find out more at www.gsk.com ... GSK plc ... behalf of GSK plc.
Edit

Roy Jakobs to join GSK Board as Non-Executive Director (Form 6-K) (GSK plc)

Public Technologies 09 Jul 2026
GSK plc ... Roy Jakobs to join GSK Board as Non-Executive Director. GSK plc (LSE/NYSE. GSK) has today announced that Roy Jakobs will join the Board of the Company as a Non-Executive Director from 13 July 2026 ... About GSK ... Find out more at gsk.com ... GSK plc.
Edit

Q2 2026 pre announcement aide memoire (GSK plc)

Public Technologies 08 Jul 2026
GSK plc published this content on July 08, 2026, and is solely responsible ...
Edit

Total Voting Rights (Form 6-K) (GSK plc)

Public Technologies 01 Jul 2026
GSK plc ... In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following. ... Notifications may be sent to company.secretary@gsk.com ... About GSK.
Edit

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above (Form 6-K) (GSK plc)

Public Technologies 29 Jun 2026
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. Form 6-K ... GSK plc ... Form 20-F . ... ... GSK PLC ... GSK plc ... behalf of GSK plc ... GSK plc published this content on June 29, 2026, and is solely responsible for the information contained herein.
Edit

Transaction in own shares (Form 6-K) (GSK plc)

Public Technologies 29 Jun 2026
GSK plc ... GSK plc (the "Company") announces today acting through Citigroup Global Markets Limited (the "Broker"), it has purchased the following number of the Company's ordinary shares of 31¼ pence each ... About GSK ... GSK enquiries.
Edit

CBCR data 2025 (GSK plc)

Public Technologies 25 Jun 2026
GSK plc published this content on June 25, 2026, and is solely responsible ...

Article Search

tools
×
×
×
×